Products
Online Inquiry
PKG drug G1
Cat. No.:
0225LY-1348
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and LC-MS.
Size:
Add to basket
Product Overview
Description:
PKG drug G1 targets C42 of PKG Ialpha; it facilitates blood pressure reduction and vasodilation through a mechanism that does not depend on C42 PKG Ialpha.
Synonym:
PKG drug G1; 374703-78-3; 4-hydroxy-5-[(Z)-(2-methylindol-3-ylidene)methyl]-1,3-dihydroimidazole-2-thione; 5-((2-Methyl-1H-indol-3-yl)methylene)-2-thioxoimidazolidin-4-one; Thiourea deriv. 8; (5E)-5-[(2-methyl-1H-indol-3-yl)methylidene]-2-sulfanylideneimidazolidin-4-one
CAS No.:
374703-78-3
Compound CID:
135402990
Formula:
C13H11N3OS
Formula Weight:
257.31
Specification
Relative Density:
1.45 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
PKG drug G1 can be used in cardiovascular research to investigate the activation of protein kinase G and its role in vasodilation.
Library Information
Target:
PKA
Receptor:
PKA
Pathways:
cAMP signaling; GPCR/G protein signaling
Plate Number:
AOCL-18
Plate Location:
c6
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
16.67 mg/mL; 64.79 mM
